Based on the observations that c‐Abl knockout28 or chemical inhibition28, 61, 67, 68, 69 is neuroprotective in animal models of PD, we believe that c‐Abl activation may be a key driver of neurodegeneration. This evidence concerns the gene ABL1 and Parkinson disease.